Cargando…

Measles outbreak in Western Uganda: a case-control study

BACKGROUND: Measles outbreaks are prevalent throughout sub-Saharan Africa despite the preventive measures like vaccination that target under five-year-old children and health systems strengthening efforts like prioritizing the supply chain for supplies. Measles immunization coverage for Kasese distr...

Descripción completa

Detalles Bibliográficos
Autores principales: Walekhwa, Abel Wilson, Ntaro, Moses, Kawungezi, Peter Chris, Achangwa, Chiara, Muhindo, Rabbison, Baguma, Emmanuel, Matte, Michael, Migisha, Richard, Reyes, Raquel, Thompson, Peyton, Boyce, Ross M., Mulogo, Edgar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220759/
https://www.ncbi.nlm.nih.gov/pubmed/34157990
http://dx.doi.org/10.1186/s12879-021-06213-5
_version_ 1783711209469509632
author Walekhwa, Abel Wilson
Ntaro, Moses
Kawungezi, Peter Chris
Achangwa, Chiara
Muhindo, Rabbison
Baguma, Emmanuel
Matte, Michael
Migisha, Richard
Reyes, Raquel
Thompson, Peyton
Boyce, Ross M.
Mulogo, Edgar M.
author_facet Walekhwa, Abel Wilson
Ntaro, Moses
Kawungezi, Peter Chris
Achangwa, Chiara
Muhindo, Rabbison
Baguma, Emmanuel
Matte, Michael
Migisha, Richard
Reyes, Raquel
Thompson, Peyton
Boyce, Ross M.
Mulogo, Edgar M.
author_sort Walekhwa, Abel Wilson
collection PubMed
description BACKGROUND: Measles outbreaks are prevalent throughout sub-Saharan Africa despite the preventive measures like vaccination that target under five-year-old children and health systems strengthening efforts like prioritizing the supply chain for supplies. Measles immunization coverage for Kasese district and Bugoye HC III in 2018 was 72 and 69%, respectively. This coverage has been very low and always marked red in the Red categorization (below the national target/poor performing) on the national league table indicators. The aim of this study was to assess the scope of the 2018–2019 measles outbreak and the associated risk factors among children aged 0–60 months in Bugoye sub-county, Kasese district, western Uganda. METHODS: We conducted a retrospective unmatched case-control study among children aged 0–60 months with measles (cases) who had either a clinical presentation or a laboratory confirmation (IgM positivity) presenting at Bugoye Health Centre III (BHC) or in the surrounding communities between December 2018 and October 2019.. Caregivers of the controls (whose children did not have measles) were selected at the time of data collection in July 2020. A modified CDC case investigation form was used in data collection. Quantitative data was collected and analyzed using Microsoft excel and STATA version 13. The children’s immunization cards and health registers at BHC were reviewed to ascertain the immunization status of the children before the outbreak. RESULTS: An extended measles outbreak occurred in Bugoye, Uganda occured between December 2018 and October 2019. All 34 facility-based measles cases were documented to have had maculopapular rash, conjunctivitis, and cough. Also, the majority had fever (97%), coryza (94.1%), lymphadenopathy (76.5%), arthralgias (73.5%) and Koplik Spots (91.2%) as documented in the clinical registers. Similar symptoms were reported among 36 community-based cases. Getting infected even after immunized, low measles vaccination coverage were identified as the principal risk factors for this outbreak. CONCLUSION: Measles is still a significant problem. This study showed that this outbreak was associated with under-vaccination. Implementing a second routine dose of measles-rubella vaccine would not only increase the number of children with at least one dose but also boost the immunity of those who had the first dose. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06213-5.
format Online
Article
Text
id pubmed-8220759
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82207592021-06-24 Measles outbreak in Western Uganda: a case-control study Walekhwa, Abel Wilson Ntaro, Moses Kawungezi, Peter Chris Achangwa, Chiara Muhindo, Rabbison Baguma, Emmanuel Matte, Michael Migisha, Richard Reyes, Raquel Thompson, Peyton Boyce, Ross M. Mulogo, Edgar M. BMC Infect Dis Research BACKGROUND: Measles outbreaks are prevalent throughout sub-Saharan Africa despite the preventive measures like vaccination that target under five-year-old children and health systems strengthening efforts like prioritizing the supply chain for supplies. Measles immunization coverage for Kasese district and Bugoye HC III in 2018 was 72 and 69%, respectively. This coverage has been very low and always marked red in the Red categorization (below the national target/poor performing) on the national league table indicators. The aim of this study was to assess the scope of the 2018–2019 measles outbreak and the associated risk factors among children aged 0–60 months in Bugoye sub-county, Kasese district, western Uganda. METHODS: We conducted a retrospective unmatched case-control study among children aged 0–60 months with measles (cases) who had either a clinical presentation or a laboratory confirmation (IgM positivity) presenting at Bugoye Health Centre III (BHC) or in the surrounding communities between December 2018 and October 2019.. Caregivers of the controls (whose children did not have measles) were selected at the time of data collection in July 2020. A modified CDC case investigation form was used in data collection. Quantitative data was collected and analyzed using Microsoft excel and STATA version 13. The children’s immunization cards and health registers at BHC were reviewed to ascertain the immunization status of the children before the outbreak. RESULTS: An extended measles outbreak occurred in Bugoye, Uganda occured between December 2018 and October 2019. All 34 facility-based measles cases were documented to have had maculopapular rash, conjunctivitis, and cough. Also, the majority had fever (97%), coryza (94.1%), lymphadenopathy (76.5%), arthralgias (73.5%) and Koplik Spots (91.2%) as documented in the clinical registers. Similar symptoms were reported among 36 community-based cases. Getting infected even after immunized, low measles vaccination coverage were identified as the principal risk factors for this outbreak. CONCLUSION: Measles is still a significant problem. This study showed that this outbreak was associated with under-vaccination. Implementing a second routine dose of measles-rubella vaccine would not only increase the number of children with at least one dose but also boost the immunity of those who had the first dose. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06213-5. BioMed Central 2021-06-22 /pmc/articles/PMC8220759/ /pubmed/34157990 http://dx.doi.org/10.1186/s12879-021-06213-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Walekhwa, Abel Wilson
Ntaro, Moses
Kawungezi, Peter Chris
Achangwa, Chiara
Muhindo, Rabbison
Baguma, Emmanuel
Matte, Michael
Migisha, Richard
Reyes, Raquel
Thompson, Peyton
Boyce, Ross M.
Mulogo, Edgar M.
Measles outbreak in Western Uganda: a case-control study
title Measles outbreak in Western Uganda: a case-control study
title_full Measles outbreak in Western Uganda: a case-control study
title_fullStr Measles outbreak in Western Uganda: a case-control study
title_full_unstemmed Measles outbreak in Western Uganda: a case-control study
title_short Measles outbreak in Western Uganda: a case-control study
title_sort measles outbreak in western uganda: a case-control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220759/
https://www.ncbi.nlm.nih.gov/pubmed/34157990
http://dx.doi.org/10.1186/s12879-021-06213-5
work_keys_str_mv AT walekhwaabelwilson measlesoutbreakinwesternugandaacasecontrolstudy
AT ntaromoses measlesoutbreakinwesternugandaacasecontrolstudy
AT kawungezipeterchris measlesoutbreakinwesternugandaacasecontrolstudy
AT achangwachiara measlesoutbreakinwesternugandaacasecontrolstudy
AT muhindorabbison measlesoutbreakinwesternugandaacasecontrolstudy
AT bagumaemmanuel measlesoutbreakinwesternugandaacasecontrolstudy
AT mattemichael measlesoutbreakinwesternugandaacasecontrolstudy
AT migisharichard measlesoutbreakinwesternugandaacasecontrolstudy
AT reyesraquel measlesoutbreakinwesternugandaacasecontrolstudy
AT thompsonpeyton measlesoutbreakinwesternugandaacasecontrolstudy
AT boycerossm measlesoutbreakinwesternugandaacasecontrolstudy
AT mulogoedgarm measlesoutbreakinwesternugandaacasecontrolstudy